Exos Asset Management’s ProKidney PROK Stock Holding History

Exos Asset Management’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$422K	Buy	+42,201	New	+$417K	0.22%	115
2022 Q1	–	Sell	-127,594	Closed	-$1.26M	–	327
2021 Q4	$1.26M	Buy	127,594 +27,594	+28%	+$273K	0.65%	46
2021 Q3	$980K	Buy	+100,000	New	+$985K	0.52%	57

Other funds holding PROK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Exos Asset Management's PROK Position: Q2 2022 in Review

Exos Asset Management opened a new position in ProKidney (PROK) in Q2 2022: 42,201 shares worth $422K. The stake represents 0.22% of the portfolio and ranks #115 among its holdings. This is a return to the name: Exos Asset Management previously reported a position in PROK as recently as Q4 2021.

Exos Asset Management first reported a position in PROK in Q3 2021 and has held it in 3 quarters since. The position peaked at $1.26M in Q4 2021. 67 funds tracked by Wall St. Rank hold PROK as of Q2 2022.

Exos Asset Management held 42,201 shares of ProKidney worth $422K as of Q2 2022.
ProKidney was a new Exos Asset Management position in Q2 2022.
ProKidney made up 0.22% of Exos Asset Management's portfolio in Q2 2022, its #115 holding.
Exos Asset Management first reported a position in ProKidney in Q3 2021 and has held it in 3 quarters since.
Exos Asset Management's ProKidney position peaked at $1.26M in Q4 2021.
67 funds tracked by Wall St. Rank held ProKidney as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.